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A Putative Mechanism for Downregulation of the
Catalytic Activity of the EGF Receptor via Direct
Contact between Its Kinase and C-Terminal Domains
and Kuriyan, 2002). A primary means of regulation in
RTKs is ligand binding to the extracellular domain, lead-
ing to dimerization or formation of higher-order oligo-
mers of the receptors and enzymatic activation (Schles-
singer, 2000, 2003). Similarly, activation of ErbB1, -3,
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Ramat-Aviv 69978 and -4 involves ligand-induced contact formation be-
tween the extracellular domains of different membersIsrael
of the ErbB family to form homo- and heterodimers
(Schlessinger, 2000). Some studies have shown that,
without a ligand, EGFR exists mostly in a monomericSummary
form and that ligands induce its dimerization and activa-
tion (Yarden and Schlessinger, 1987). On the other hand,Tyrosine kinase receptors of the EGFR family play
recent studies have demonstrated that while required,a significant role in vital cellular processes and in
dimerization is not sufficient for activation and that invarious cancers. EGFR members are unique among
the absence of a ligand, stable, inactive dimers exist inkinases, as the regulatory elements of their kinase
a form in which contact between monomers involvesdomains are constitutively ready for catalysis. Never-
the transmembrane and intracellular domains (Biswastheless, the receptors are not constantly active. This
et al., 1985; Gadella and Jovin, 1995; Moriki et al., 2001;apparent paradox has prompted us to seek mecha-
Yu et al., 2002). Experimental evidence (Cadena et al.,nismsof regulation in EGFR’s cytoplasmic domain that
1994), as well as the computational results presenteddo not involve conformational changes of the kinase
below, demonstrates that the C-terminal domain playsdomain. Our computational analyses, based on the
a role in such contact formation.three-dimensional structure of EGFR’s kinase domain
In most tyrosine kinases (TKs) excluding the ErbBs,suggest that direct contact between the kinase and
an important means of regulation involves profounda segment from the C-terminal regulatory domains
structural changes along with transautophosphorylationinhibits enzymatic activity. EGFRactivationwould then
of the kinase domain (Schlessinger, 2000). In contrast,involve temporal dissociation of this stable complex,
the ErbB family is unique in that activation is indepen-for example, via ligand-induced contact formation
dent of its phosphorylation state (Gotoh et al., 1992). Thebetween the extracellular domains, leading to the re-
structure of the apo-EGFR kinase domain demonstratedorientation of the transmembrane and intracellular
that its unphosphorylated conformation was, in es-domains. The model provides an explanation at the
sence, identical to the phosphorylated conformationsmolecular level for the effects of several cancer-caus-
of other TKs (Stamos et al., 2002).ing EGFR mutations.
Recently, a structure of the kinase domain of the EGFR
in complex with the inhibitor GW572016 (Lapatinib) was
Introduction determined (Wood et al., 2004). This structure shows
several differences, including different conformations of
The epidermal growth factor receptor (EGFR) family of the substrate and ATP binding sites (Wood et al., 2004),
receptor tyrosine kinases (RTKs), also known as ErbB from either the structure of the apo-EGFR or of EGFR
or HER, consists of four members, ErbB1, -2, -3, and -4 bound to the OSI-774 (Tarceva) inhibitor (Stamos et al.,
(Schlessinger, 2000). The receptors, which are activated 2002). The authors have suggested that these differ-
by some dozen ligands, including EGF and TGF, play ences are due to the fact that the conformation seen in
an important role in the control of many fundamental the GW572016 bound kinase domain reflects an inactive
cellular processes (Schlessinger, 2000). Mutations and state that is accessible to the kinase domain under phys-
overexpression of the ErbBs have been implicated in iological conditions. However, GW572016 is very bulky
malignant diseases such as carcinoma and glioblas- in comparison to OSI-774. Thus, as the authors indi-
toma and are linked with aggressive disease, resistance cated, another possibility is that the differences in the
to chemotherapy, and poor survival (Dancey, 2004). Ac- structures are due to the inhibitor’s large size, which
cordingly, the ErbBs are attractive targets for anticancer forces a conformation that is far from native. That the
drugs (Cho et al., 2003; Yarden and Sliwkowski, 2001). apo-EGFR kinase domain is seemingly in a constitutively
Structurally, the ErbBs consist of an N-terminal, extra- active conformation (Stamos et al., 2002) leads to an
cellular domain that is connected by a short transmem- apparent paradox, since it is well established that ErbBs
brane span to a tyrosine kinase domain, which is in turn are not constitutively active (Schlessinger, 2000). Hence,
followed by a C-terminal domain. our working hypothesis, as presented in Figure 1, was
In all RTKs, including the ErbBs, the active kinase that ErbBs are regulated by another mechanism intrinsic
triggers a wide spectrum of crucial intracellular signaling to the intracellular domain; one that is phosphorylation
events (Schlessinger, 2000), and their catalytic activity independent.
is encapsulated in multiple layers of regulation (Huse The orphan receptor ErbB2 presents an even more
intriguing case than other members of the EGFR family
because its activation is not only phosphorylation inde-*Correspondence: bental@ashtoret.tau.ac.il
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Figure 1. Schematic Diagram Representing
the Suggested Model of EGFR Activation
Two EGFR monomers are colored light purple
and yellow. The extracellular domain (resi-
dues 1–620, labeled I, II, III, and IV according
to its subdomains) and the kinase domain
(residues 685–957) are connected via a trans-
membrane helix (residues 621–642) and a
short juxtamembrane segment (not shown).
The C-terminal domain, comprising 229 amino
acids, whose structure has not been deter-
mined, follows the kinase domain. Tyrosine
residues (Y) known as the autophosphoryla-
tion sites in the C-terminal domain are indi-
cated. In the inactive conformation (left), each
of the extracellular domains assumes a com-
pact structure, and the intracellular domains
contact via the C-terminal fragments, leading
to an inactive and stable form. Activation
(right) occurs when ligands (purple ovals)
bind to the extracellular domains, leading to
the formation of a stable extracellular con-
tact, which is followed by the rotation of the transmembrane helices and the subsequent destabilization of the contacts between the C-ter-
minal and kinase domains. The kinase can now transautophosphorylate the tyrosine residues of its own C-terminal domain, as well as tyrosine
residues of its protein substrates. The figure displays an illustration of the transmembrane domain; the suggested molecular model for the
transmembrane domain in the active and inactive states was presented in (Fleishman et al., 2002). Positive and negative charges are marked
in the active conformation on the kinase and C-terminal domains, respectively. In the inactive conformation, they roughly neutralize each
other (Figure 2).
pendent, but also ligand independent (Cho et al., 2003). et al., 2003; Massoglia et al., 1990; Riedel et al., 1987).
Variations in the C-terminal domain of ErbB receptorsThe absence of clear regulation of ErbB2 activation
prompted us to propose a molecular mechanism for are known to be responsible for the alterations in the
transforming potential and type of malignant diseasesrotation-coupled activation of this receptor (Fleishman
et al., 2002). Specifically, the transmembrane domain of due to the expression of v-ErbBs in affected cells (Ga-
mett et al., 1986; Pelley et al., 1989; Raines et al., 1988).an ErbB2 homodimer may occupy one of two stable
conformations, corresponding to the active and inactive The increased substrate-phosphorylation capacity of
the C-terminally impaired EGFR is not attributed tostates of the receptor. The switch between the two con-
formations, involving a rotation of the transmembrane lesser degradation and internalization, but rather to an
enhanced rate of autophosphorylation (Robinson et al.,domain (Jiang and Hunter, 1999), induces the reorienta-
tion of the cytoplasmic domains within receptor dimers, 1992), thus providing direct evidence for a relationship
between C-terminal domain impairment and increasedthus leading to transautophosphorylation and stimula-
tion of enzymatic activity. In this paper, we shall analyze catalysis.
Here, we propose a molecular model clarifying somethe implications of this mode of activation on the confor-
mation of the intracellular kinase domain. of the ambiguity regarding the role of the C-terminal
domain in ErbB regulation. According to the model (Fig-The C-terminal domain plays a role in the internaliza-
tion and degradation of the EGFR (Chang et al., 1995) ure 1), contact between the intracellular domains of the
EGFR within a dimer leads to receptor inactivation, whileand in EGFR’s regulation by other molecules (Huse and
Kuriyan, 2002). This domain also serves as a docking ligand-induced contact between the extracellular do-
mains leads to rotation-coupled activation (Fleishmansite for protein modules that bind the phosphotyrosines
on the activated receptors (Schlessinger, 2000). In addi- et al., 2002; Jiang and Hunter, 1999; Moriki et al., 2001)
by destabilization of the intermonomer contacts in thetion to these roles, the importance of the C-terminal
domain for proper functioning of the EGFR was pre- cytoplasmic domain. According to this scenario, interac-
tions between the intracellular domains regulate acti-viously noted on the basis of studies of viral and other
mutant EGFR members (Boerner et al., 2003; Chang et vation (Burgess et al., 2003; Chantry, 1995), and the
C-terminal domain acts as an inherent negative regula-al., 1995; Wedegaertner and Gill, 1992).
Naturally occurring retroviral oncogene variants (v-ErbB) tor of the EGFR’s activity. This model offers a molecular
mechanism that underlies the tumorigenic activity ofare an extracellular domain-truncated form of the EGFR
gene that affects cell growth, motility, and survival (Ga- EGFR mutants.
mett et al., 1986). These v-ErbB variants share striking
homology with mutants of the human EGFR members Results
that have been identified in gliomas and carcinomas
(Frederick et al., 2000). Truncation of the extracellular Geometric Complementarity between the Kinase
and C-Terminal Domainsdomain is insufficient to manifest the transforming prop-
erties of the different v-ErbB variants; these properties The crystal structure of the EGFR (Stamos et al., 2002)
(PDB entries 1m14 and 1m17) includes the kinase do-are probably related to amino acid replacements, inser-
tions, and deletions in the C-terminal domain (Boerner main (residues 685–957) and a segment from the
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Figure 2. Geometric and Electrostatic Com-
plementarity between the Kinase and C-Ter-
minal Domains
(A) A space-filled model of EGFR’s homodi-
meric complex (Stamos et al., 2002) showing
the geometric complementarity within the
complex. The kinase domains are colored
light purple and yellow, the C-terminal frag-
ments are colored cyan, and the inhibitor is
colored purple. The dimer is symmetric,
which means that each kinase domain is in
contact with both C-terminal fragments,
yielding one large and one small interface per
monomer. The interactions with the C termi-
nus are identical in both monomers. Figure
2A was made by using MOLSCRIPT (Kraulis,
1991) and Raster3D (Merritt and Bacon,
1997).
(B–D) A projection of the electrostatic poten-
tial (φ) onto the molecular surface of the ki-
nase domain and the C-terminal fragment
that comprise the complex in (A);φ 10 kT/e
is dark blue, φ  0 is white, and φ  10
kT/e is dark red. Yellow ellipses mark the in-
terfaces between the kinase domains and the
C-terminal fragments. The figures were produced by using GRASP (Nicholls et al., 1991). (B) The left-most kinase domain shown in (A) (yellow)
was rotated 90 to the left relative to its orientation in (A). (C) The C-terminal fragment is shown in the same orientation as the upper segment
in (A). (D) The right-most kinase domain shown in (A) (light purple) was rotated 90 to the right relative to its orientation in (A). The electrostatic
complementarity between the negatively charged C-terminal fragment and the positively charged residues of the kinase domain that interact
with it is noticeable.
C-terminal domain (residues 977–995). The crystal struc- ErbBs contained 8–10 acidic and no basic residues (Fig-
ure 3). These residues produced a highly negative elec-ture reveals six putative dimer forms (Stamos et al.,
2002). We focus here on the one with the largest inter- trostatic potential (Figure 2C). Thus, the kinase domain
and the C-terminal fragments form complementary sur-subunit interface. In this complex, the kinase domain
was found as a symmetric homodimer (Figure 2A), in faces in terms of their electrostatic potential. The geo-
metric and charge complementarity (Figures 2B–2D),which two copies of the fragment of the C-terminal do-
main mediate contact between the two kinase domains. together with the significant size of the interface (Figure
2A), are indicative of the stability of the complex andThis dimer is also the only one in which the kinase do-
mains’ N termini are facing in the same direction, in suggest that it may be biologically meaningful.
Following the experiments of Chang et al. (1995) dis-accordance with the physiological requirement that the
two domains connect to the membrane bilayer. cussed below, we simultaneously substituted each of
the negatively charged residues 979–982 (DEED, FigureWe calculated the water-accessible surface area of
the kinase domain alone and within the homodimeric 3) in the C-terminal domain with its polar equivalent, i.e.,
D→N and E→Q. The mutated C-terminal fragment iscomplex. Each kinase monomer contacts two C-ter-
minal fragments (Figure 2A). The water-accessible sur- much less negatively charged than the native fragment
(Figure 4B), and this difference in charge obstructs itsface areas of these interfaces are 1419 A˚2 and 1048 A˚2.
Thus, the total interface between each monomer of the electrostatic complementarity with the kinase domain
and presumably destabilizes the complex. We furtherkinase domain and the C-terminal fragments is 2467 A˚2,
and the interface within the entire complex is twice as mutated the same positions to four positively charged
lysine residues (Figure 4C). Electrostatic analysis of thelarge, constituting a very large interface compared to
typical interprotein interfaces (Jones and Thornton, mutated C-terminal fragment displayed a positive po-
tential at the N-terminal region of the fragment, which1996).
would lead to its electrostatic repulsion from the kinase
domain. To test whether the charge complementarity isCharge Complementarity between the Kinase
and C-Terminal Domains
Electrostatic calculations show strong positive potential
in the kinase domain at its interface with the C-terminal
fragments (Figures 2B and 2D). This potential originates
from positively charged residues in both subunits, sug-
gesting that the kinase domains would repel one another
in the absence of the C-terminal fragments. Kinase do- Figure 3. Abundance of Acidic Residues in the Fragment of the
mains from other ErbBs, which were constructed by C-Terminal Domain
using homology modeling, displayed similar positive The multiple sequence alignment of the C-terminal segments of the
electrostatic potentials in the corresponding regions four human members of the ErbB family. Each segment contains
between 8 and 10 acidic residues (marked in red).(data not shown). The C-terminal fragment of all of the
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Figure 4. Electrostatic Analysis of Reported
and Novel Mutations in the EGFR C-Terminal
Fragment
A projection of the electrostatic potential (φ)
onto the molecular surface of the C-terminal
fragment; the color coding is as in Figures
2B–2D.
(A) The C-terminal fragment of the native
EGFR, in the same orientation as in Figure 2C
(central image), rotated 90 to the right (right
image) or left (left image). The location of se-
lected residues is marked.
(B) The C-terminal fragment, in the same ori-
entations as in (A), in which the negatively
charged residues in the 979–982 positions
(DEED) were mutated to their polar equivalent
(NQQN).
(C) The C-terminal fragment, in the same ori-
entations as in (A), in which the same posi-
tions were mutated to positively charged ly-
sine residues.
unique to ErbBs among TKs, we examined the electro- residues and are buried at the interface of the EGFR
complex. Of these residues, two are positively chargedstatic potentials of a few TKs of known structures as
described in the Supplemental Data (available with this (Lys822 and Lys828 on the kinase domain) and two are
negatively charged (Asp988 and Asp990 on the C-ter-article online; Electrostatic calculations). These domains,
which were derived from remotely related proteins, dis- minal fragment) (Figure 5B).
Polar networks, such as the one observed in the EGFRplay diverse electrostatic characteristics. In particular,
they do not share EGFR’s strong positive electrostatic interface (Figure 5B), significantly increase the stability
of complexes and contribute to the binding specificitypotential at the interface with the C-terminal fragments
(data not shown), suggesting that such electrostatic in- (Sheinerman et al., 2000). Therefore, mutations of charged
positions in the network would alter the stability of theteractions between the kinase and the C-terminal do-
mains are specific to the ErbBs. complex (Serrano et al., 1990). An even larger effect
would be obtained by mutating them in pairs. For exam-
ple, mutating Lys822 and Lys828 to aspartates or Asp988A Network of Ion Pairs and Hydrogen
and Asp990 to lysines altered the electrostatic surfaceBonds at the Interface
of the kinase domain and the C-terminal fragment, re-Our analysis demonstrated that a network of salt bridges
spectively (Figure 6). Such mutations would impinge onand hydrogen bonds connects the two adjacent kinase
the formation of the EGFR complex and kinase acti-domains through the C-terminal fragments (Figure 5B).
vation.We identified four charged residues within this network
that are involved in several interactions with neighboring The importance of the network for the stability of the
Figure 5. A Network of Ion Pairs and Hydro-
gen Bonds across the Interface of the EGFR
Complex
The kinase domain monomers are displayed
as ribbons and colored light purple and yel-
low. The C-terminal fragment is colored cyan.
(A) The EGFR homodimeric complex (Stamos
et al., 2002) as viewed with a clockwise rota-
tion of about 90 compared to Figure 2A.
(B) A close view, in the same orientation as
in (A), of the polar network connecting the
C-terminal fragment with its two adjacent ki-
nase domains. The C atoms of residues
comprising the polar network are displayed
as spheres. Four selected residues in the net-
work (Lys822, Lys828, Asp988, Asp990; their
side chains displayed as sticks) are buried in
the core of the kinase/C-terminal fragment
interface, suggesting that they play a key role
in complex stabilization (Sheinerman et al.,
2000). Solid pink lines connect the C (or
nearest neighbors) atoms of residues that form ion pairs and hydrogen bonds in the network. By symmetry, identical interactions connect
residues between the second C-terminal fragment and the kinase domains (not shown). Each residue in the network is involved in a few
interactions with neighboring residues. For instance, Asp990, located on the C-terminal domain, interacts with Lys822, located on one kinase
domain monomer (yellow), and with Lys799, located on the second kinase domain monomer (light purple), presumably stabilizing the complex.
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reorientation of the transmembrane domains (Fleishman
et al., 2002; Jiang and Hunter, 1999; Moriki et al., 2001)
and, subsequently, to rearrangements in the cyto-
plasmic domains (Figure 1). Any reorganization of the
cytoplasmic complex, followed by a change in the posi-
tion of the negatively charged C-terminal fragment,
would lead to electrostatic repulsion between the two
positively charged kinase monomers (Figure 2). Hence,
this model of conformational changes during receptor
activation may constitute a hitherto unknown mode of
regulation.
Strong reinforcement of this model of regulation is
provided by data on the EGFR analog c-ErbB (Chang
et al., 1995). Deletions of a C-terminal fragment of this
receptor (corresponding to residues 966–1006 of the
EGFR) lead to higher autokinase activity compared to
normal c-ErbB and transforming ability in vitro and
Figure 6. Electrostatic Analysis of Novel Mutations in the EGFR Ki- in vivo. Moreover, a mutant in which the four consecutive
nase and C-Terminal Domains acidic residues EEED were replaced by the polar seg-
A projection of the electrostatic potential (φ) onto the molecular ment QQQN showed higher autokinase activity and a
surface of the kinase domain and the C-terminal fragment; the color partial transformation phenotype. Since the two mutants
coding is as in Figures 2B–2D. and normal receptors have similar rates of degradation,
(A) The native kinase domain in the same orientation as in Fig-
the higher transforming ability of the mutants could noture 2D.
be attributed to a longer half-life of the mutant receptor(B) The R822D/R828D double mutant EGFR kinase domain in the
(Chang et al., 1995). These data are consistent with oursame orientation as in (A).
(C) The native C-terminal fragment of the EGFR rotated 90 to the results. The four acidic residues, which correspond to
left relative to its orientation in Figure 2C. the DEED segment (Asp979–Asp982) in the EGFR, are
(D) The D988R/D990R double mutant C-terminal domain in the same located on the C-terminal fragment (Figure 3) that forms
orientations as in (C).
contact with the kinase domain. Our analysis showed
that these positions contribute significantly to the nega-
tive electrostatic potential of the fragment (Figure 2),complex can be tested experimentally by using the dou-
and their substitution with polar residues reduces theble mutant cycle approach (Serrano et al., 1990). Briefly,
complementarity between the kinase and C-terminal do-if the additive effects of mutating two residues sepa-
mains (Figure 4B), presumably destabilizing the inactiverately (e.g., Lys822→Asp and Asp990→Lys) is signifi-
complex.cantly different from the effect of mutating the same
Internal deletions of segments in the C-terminal do-two residues simultaneously, then the two positions are
main of the EGFR have also been detected in naturallyinterdependent (Serrano et al., 1990), e.g., are involved
occurring EGFR mutants, which display tumorigenicin a salt bridge. Based on our analysis of the network,
properties. For example, an internal deletion of residueswe suggest using a double mutant cycle, in which each
959–1030 has been detected in EGFRs sequenced fromstep involves mutating a pair of similarly charged resi-
human glioblastomas (Boerner et al., 2003; Chang et al.,dues in the EGFR interface, as specified above.
1995; Frederick et al., 2000). Some viral ErbBs contain an
in-frame deletion of 139 residues within the intracellular
Model of C-Terminal Domain Regulation region, immediately following the kinase domain (Boerner
of Kinase Activity et al., 2003; Chang et al., 1995; Frederick et al., 2000).
One of the phosphorylation sites of the C-terminal do- This region contains the C-terminal fragment contacting
main (Tyr992) is located on the fragment that forms con- the kinase domain according to the X-ray structure
tact with the kinase domain and is therefore inaccessible (Stamos et al., 2002). Our model suggests that the inter-
to phosphorylation in this conformation. The catalytic nal deletions in the C-terminal domain yield constitu-
sites in the kinase domains are facing away from each tively active forms of EGFR by means of destabilization
other in the complex; therefore, transphosphorylation of the inactive complex.
of residues on the kinase domain is improbable. The
above two observations suggest that the EGFR crystal
structure represents an inactive form of the receptor. Evolutionary Conservation Analysis
The kinase domain of ErbB3 has no catalytic activity,The EGFR participates in imperative cell processes and
ought to remain inactive under most physiological con- yet it dimerizes with other members of the ErbB family
to produce heterodimers with highly efficient catalyticditions (Huse and Kuriyan, 2002). Therefore, its inactive
state should be very stable. Indeed, the complex in the activity (Schlessinger, 2000). These distinct features are
manifested in the evolutionary-conservation analysis.crystal structure of the EGFR appears to be stable,
based on the geometric and charge complementarity, ErbB3’s kinase domain displays variations in the cata-
lytic site in comparison to other members of the ErbBfurther supporting the notion that this complex is inac-
tive. It has been suggested that ligand-induced contact family, thus rendering it inactive. However, the interface
between the kinase domain and the C-terminal fragmentformation of the extracellular domains would lead to
Structure
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is highly conserved within the ErbBs and their orthologs,
including ErbB3. As a reference, an analysis of 121 ki-
nase domains from various TKs showed that the cata-
lytic site, including the ATP and substrate binding loop,
was highly conserved, whereas the interface between
the kinase domain and the C-terminal fragment was
highly variable (data not shown).
Overall, the conservation analysis provides further
support for the suggestion that the dimeric complex
observed in the crystal structure is not common to all
the TKs. However, the contact area between the kinase
and C-terminal domains in this complex is common to
the ErbBs, which thus maintain the ability to produce
homo- and heterodimers through the same interface.
A Network of Correlated Amino Acid Substitutions
between Regulatory Elements
By and large, all TKs carry out the same catalytic pro-
cess. Thus, key residues in the kinase domain, which
are responsible for catalysis of phosphotransfer, are
under strong evolutionary constraint, as mentioned
above. However, in order for the kinases to be involved
in numerous and distinct signal transduction pathways,
each kinase family exhibits variations in its amino acid
sequence that are necessary for the modification of the
mode of regulation. Since multiple positions are involved
in determining these traits, these sequence variations
should occur concomitantly in relevant regulatory ele-
ments. In other words, during evolution, substitutions
of one residue in regulatory elements may be compen-
sated by a concurrent change in another residue, in
order to maintain the structural or functional relationship
Figure 7. Evolutionarily Correlated and Specificity-Determining Amino
between these positions (Fleishman et al., 2004b). Acid Sites
In order to look for particular positions that could play The EGFR homodimeric complex (Stamos et al., 2002) as viewed
a role in regulation, we analyzed the set of 121 multiply with an upward rotation of about 180 compared to Figure 2A. The
aligned TKs of diverse families in search of pairs of kinase domains, presented by using trace models, are colored light
purple and yellow, the C-terminal fragments are colored cyan, andamino acid positions that might be evolutionarily corre-
the inhibitor is shown as a purple space-filled model. The C helixlated (Fleishman et al., 2004b). The analysis revealed
(residues 729–744) and the activation loop (residues 831–852) are152 pairs of correlated residues, among which we identi-
colored green.
fied a network of 14 highly intercorrelated positions (Fig- (A) The residues in the cluster of the most significant pairs of corre-
ure 7A and Table 1). lated amino acid sites are displayed as space-filled models. Solid
The kinase domain includes several regulatory ele- pink lines connect a few of the pairs of correlated residues (high-
lighted in Table 1) in the EGFR homodimer. Correlations within thements, such as the C helix and activation loop, which
kinase domain are demonstrated only on the left monomer, andplay a role in allosteric regulation and are responsible
correlations between the kinase and the C-terminal domains arefor conformational changes. These elements function
demonstrated only on the upper interface. The correlations between
together to control activation, i.e., their movements are known regulatory elements, such as the C helix and the activation
concurrent and their conformations are mutually depen- loop and the interface between the kinase domain and C-terminal
dent (Huse and Kuriyan, 2002). Our analysis showed fragment, suggest that the latter may also be involved in regulation.
(B) The main specificity-determining residues are located on the Cpairs of evolutionarily correlated positions in these
helix, the activation loop, the C-terminal fragment, and its interfacesknown regulatory elements. For example, Ala743, which
on the kinase. This suggests that the regulatory elements in theis located on the C helix, is correlated with Gly849 of
EGFR had evolved specifically to stabilize the active conformation.
the activation loop (Figure 7A). Concurrently, an alternative negative regulatory mechanism had
The LVI segment (residues 955–957) of EGFR and its evolved in the form of the inactive complex between the kinase and
equivalent segments in other ErbBs are necessary for the C-terminal domains. The figures were made by using MOL-
SCRIPT (Kraulis, 1991) and Raster3D (Merritt and Bacon, 1997).ligand-independent dimerization of the EGFR intracellu-
lar domains and for transphosphorylation in ErbB2 and
ErbB3 heterodimers through allosteric regulation (Stamos
et al., 2002). Leu955 in this LVI segment is correlated domains are important for regulation (Huse and Kuriyan,
2002; Stamos et al., 2002); for example, mutations inwith Tyr740, which is located on the C helix (Figure
7A). The association of the C helix with a known dimer- Leu955 or Tyr740 severely impaired the kinase activity
of the EGFR (Stamos et al., 2002; Walker et al., 1998).ization motif exemplifies interdomain relationships be-
tween regulatory elements in the ErbBs. Both of these Based on these results, we concluded that this net-
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Shewchuk et al., 2000). Accordingly, evolutionary corre-Table 1. Correlated Pairs in the TK Family
lation between the kinase and C-terminal domains is
Pairs of Correlated Positions Correlation Coefficients
expected to be general. The mechanism by which direct
Ala726-Lys730 0.65 (0.49, 0.78) contacts control activation may vary between the ki-
Ala726-Ser888 0.60 (0.34, 0.77) nases and could not be inferred from the evolutionary-
Ala726-Lys946 0.45 (0.20, 0.64)
correlation analysis. We anticipate that in the ErbBs,Lys730-Ser888 0.59 (0.37, 0.76)
the direct contact between the kinase and C-terminalTyr740-Tyr954 0.45 (0.19, 0.67)
domains regulates catalysis by the formation of the inac-Tyr740-Leu955 0.48 (0.21, 0.69)
Ala743-Asn792 0.50 (0.19, 0.76) tive dimer shown in Figure 2A.
Ala743-Gly849 0.47 (0.18, 0.72)
Ala743-Ser888 0.45 (0.21, 0.69)
Specificity Determinants in Regulatory RegionsAla743-Lys889 0.51 (0.14, 0.73)
Ala743-Val987 0.54 (0.34, 0.72) Although TKs share an identical catalytic mechanism,
Asn792-Gly849 0.48 (0.26, 0.70) each kinase family is regulated by various means, re-
Asn792-Ser888 0.50 (0.25, 0.72) sponds to different ligands, and activates diverse sub-
Gly849-Tyr954 0.56 (0.29, 0.76)
strates. It is anticipated that certain positions wouldSer888-Lys946 0.61 (0.40, 0.78)
be responsible for these different traits, and would beLys946-Asp950 0.52 (0.31, 0.69)
reflected in their patterns of substitution (Fleishman etAsp950-Tyr954 0.48 (0.31, 0.65)
Asp950-Leu955 0.50 (0.26, 0.67) al., 2004a). Due to such differences in functions, these
Tyr954-Leu955 0.54 (0.32, 0.72) positions are not expected to be strictly conserved in
Tyr954-Asp985 0.50 (0.30, 0.67) evolution. Rather, they should be conserved among ki-
Tyr954-Val987 0.52 (0.36, 0.67)
nases of similar functions in different species (orthologs),Asp985-Val987 0.52 (0.36, 0.67)
and would differ in paralogs. Substitutions involving
A list of 22 pairwise correlations between positions comprising the these residues are presumably responsible for certain
most significant cluster of correlated residues. The trimmed means alterations in the functions of the various families of the
in the 95% confidence interval of correlations (r ), which were calcu-
TK superfamily.lated from 400 bootstrapping samples, are indicated, and the 95%
We have identified some of these specificity-determin-confidence interval is shown in parentheses (see the Supplemental
Data). The numbering of the positions is done according to the ing amino acid positions in a set of 121 multiply aligned
EGFR sequence. The pairs of positions that are located on known TKs. The main specificity-determining residues are pre-
regulatory regions are highlighted in bold and are connected by sented in Figure 7B, and their locations are indicated
solid pink lines in Figure 7A. in Table 2. The list includes residues from the known
regulatory regions, as well as residues that connect the
kinase and the C-terminal domains and participate inwork of correlations identified amino acids playing a
the polar network across the interface (Figure 5B).role in regulation. Interestingly, the same cluster also
displays correlations between residues mediating con-
tact between the kinase and C-terminal domains. Tyr954 Discussion
is located on the kinase domain and contacts the
C-terminal fragment. This residue is in close proximity ErbBs are structurally unique among TKs, as all of the
catalytic elements in their kinase domains are ready forto, and is highly correlated with, residues Asp985 and
Val987 of the C-terminal fragment (Figure 7A). Taken phosphotransfer at all times (Stamos et al., 2002). Yet,
various functional assays show them not to be constitu-together, these correlations consolidate our hypothesis
that the contact between the kinase and C-terminal do- tively active (Schlessinger, 2000). The absence of a cen-
tral regulatory module raises a fundamental dilemma,mains is biologically meaningful.
The same cluster of 14 highly intercorrelated positions namely, what prevents the receptors from being spuri-
ously activated? One possible mechanism is that changesalso includes correlations between positions at the inter-
face of the kinase domain and the C-terminal fragment in the relative orientation of the subunits within a dimer
control activation, as suggested by the model of rota-and known regulatory elements. For instance, Tyr954
located on this interface is correlated with Gly849 of the tion-coupled activation (Jiang and Hunter, 1999). Ac-
cording to this view, contact formation between the ex-activation loop, with Leu955 of the LVI segment, and
with Tyr740 of the C helix (Figure 7A). This network of tracellular domains leads to reorientation in the
transmembrane domain, which is propagated into thecorrelations suggests that this interface is also involved
in regulation. cytoplasm (Fleishman et al., 2002; Jiang and Hunter,
1999; Moriki et al., 2001). Thus, the reorientation of theVal987 of the C-terminal fragment is correlated with
Ala743, which is located on the C helix (Figure 7A). In kinase domains vis-a`-vis each other serves as a molecu-
lar switch that turns the kinase domains “on.” Whatthis context, it is important to note that the C-terminal
domain is a vital modulator of TKs’ activity (Jorissen et might be the mechanism by which this reorientation is
translated into kinase activation is not yet clear.al., 2003; Schlessinger, 2000), as was elaborated above.
For example, structure determination and mutagenesis Understanding the molecular details of how the ErbB
proteins are regulated will most probably have to awaitexperiments have shown that the kinase domains of the
insulin, the Tie2, and the platelet-derived growth factor the emergence of a structure of the full-length receptor
in oligomeric complexes. The structures of parts of the receptor (PDGFR) TKs are autoinhibited by their
C-terminal domains through direct contacts with the kinase and the extracellular domains available today
only provide a fragmentary view of the regulatory ele-kinase domain (Chiara et al., 2004; Noelle et al., 2000;
Structure
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Table 2. Specificity Determinants in the TK Family
Position Correlation Coefficients Location and Putative Functional Role in the EGFR
Lys715 0.23 (0.11, 0.36) Located on the kinase at the large interface with the C-terminal fragment; participates in the
polar network across the interface (Figure 5).
Pro770 0.24 (0.07, 0.39 Located on the kinase at the large interface with the C-terminal fragment.
Val795 0.29 (0.17, 0.40) Located on the kinase at the small interface with the C-terminal fragment.
Ile942 0.24 (0.13, 0.36) Located on the kinase at the small interface with the C-terminal fragment.
Lys799 0.24 (0.10, 0.36) Located on the kinase at the small interface with the C-terminal fragment; participates in the
polar network across the interface (Figure 5).
Glu734 0.27 (0.12, 0.42) Located on the C helix of the kinase domain; involved in regulation.
Ala743 0.29 (0.14, 0.42) Located on the C helix of the kinase domain; involved in regulation.
Arg808 0.23 (0.12, 0.35) Located on the kinase domain, close to the activation loop. Involved in hydrogen bonds that
stabilize the activation loop (Stamos et al., 2002).
Arg865 0.26 (0.10, 0.41) Located on the kinase domain, close to the activation loop. Involved in hydrogen bonds that
stabilize the activation loop (Stamos et al., 2002).
Gly849 0.28 (0.18, 0.37) Located on the activation loop of the kinase domain; involved in regulation.
Leu955 0.29 (0.13, 0.42) A part of the “LVI motif”. Important for dimerization of the kinases.
Val956 0.29 (0.17, 0.42) A part of the “LVI motif”. Important for dimerization of the kinases.
Ile957 0.25 (0.08, 0.39) A part of the “LVI motif”. Important for dimerization of the kinases.
His964 0.29 (0.15, 0.43) A putative negative regulator of EGFR’s activity; located on the C-terminal domain.
Leu965 0.24 (0.10, 0.39) A putative negative regulator of EGFR’s activity; located on the C-terminal domain.
Ser967 0.23 (0.10, 0.35) A putative negative regulator of EGFR’s activity; located on the C-terminal domain.
Pro968 0.26 (0.13, 0.40) A putative negative regulator of EGFR’s activity; located on the C-terminal domain.
Ser971 0.27 (0.13, 0.38) A putative negative regulator of EGFR’s activity; located on the C-terminal domain.
Tyr974 0.30 (0.16, 0.43) A putative negative regulator of EGFR’s activity; located on the C-terminal domain.
Asp984 0.31 (0.19, 0.44) A putative negative regulator of EGFR’s activity; located on the C-terminal fragment;
participates in the polar network across the interface (Figure 5).
Ala989 0.25 (0.13, 0.38) A putative negative regulator of EGFR’s activity; located on the C-terminal fragment;
participates in the polar network across the interface (Figure 5).
Glu991 0.25 (0.11, 0.41) A putative negative regulator of EGFR’s activity; located on the C-terminal fragment;
participates in the polar network across the interface (Figure 5).
Leu993 0.29 (0.17, 0.41) A putative negative regulator of EGFR’s activity; located on the C-terminal fragment;
participates in the polar network across the interface (Figure 5).
Tyr992 0.24 (0.11, 0.38) An autophosphorylation site, located on the C-terminal fragment; participates in the polar
network across the interface (Figure 5).
A list of 24 out of 47 residues that were identified as specificity determinants (Fleishman et al., 2004a). The location of each residue in the
EGFR sequence and its functional role are indicated. The trimmed means in the 95% confidence interval of correlations (r ), which were
calculated from 400 bootstrapping samples, are indicated, and the 95% confidence interval is shown in parentheses (see the Supplemental
Data). In addition to the residues presented above, the list of specificity determinant includes the following residues: V750, Q763, L775, E780,
D783, N792, V821, Q825, T830, S888, K889, I899, S901, I902, P910, K925, S933, D950, Q952, Q958, G959, D960, and E961. Their putative
roles remain to be tested experimentally.
ments in the structure. In Figure 1, we suggest a model Moriki et al., 2001). This switch in the orientation of the
transmembrane helices leads to the destabilization offor such regulation in the ErbB family; this model is
based on the available structures and is supported by the inactive intracellular dimer. The C-terminal domain
detaches from the kinase domain and may undergoa large body of biochemical and physiological data.
The role of the C-terminal domain as a modulator of phosphorylation, making the kinase accessible to its
substrates (Moriki et al., 2001).kinase activity has been discussed extensively (Cadena
et al., 1994; Jorissen et al., 2003), especially in the v-ErbB The structure of the GW572016 bound EGFR com-
prises the kinase domain and part of the C-terminalproducts (Boerner et al., 2003). Our results offer a model
of the molecular mechanism for this modulation (Figure domain that is packed along the kinase domain. In this
structure, the C-terminal domain partly blocks the ATP1). In the inactive state (Figure 1, left), the EGFR extracel-
lular domains assume a tethered structure (Ferguson et binding site (Wood et al., 2004), as in the inactive forms
of the myosin light chain kinase of the Ser/Thr kinaseal., 2003) that hinders contact formation between the
two subunits (Burgess et al., 2003). In this conformation, family (Huse and Kuriyan, 2002) and the Tie2 RTK (Shew-
chuk et al., 2000). That the GW572016 bound EGFRthe extracellular domains are connected to the trans-
membrane helices in their inactive state (Fleishman et structure shows an inactive conformation that is not
primed for catalysis suggests that activation of the EGFRal., 2002), thereby maintaining the intracellular domains
as a stable, inactive dimer (Figure 2A). In this state, the involves conformational changes within the kinase do-
main, in contrast to the view that the kinase domain isC-terminal domain is in contact with the kinase domain
and is inaccessible to downstream substrates (Cadena constitutively ready for phosphotransfer (Stamos et al.,
2002). We note, however, that the new structure sug-et al., 1994). Ligand-induced activation of the EGFR (Fig-
ure 1, right) leads to conformational changes in the ex- gests an important role for the C-terminal domain in
stabilizing an inactive conformation of the kinase do-tracellular domains, allowing contact formation between
the two subunits (Ogiso et al., 2002), followed by a rota- main (Wood et al., 2004); this finding is in harmony with
the model of activation suggested here.tion of the transmembrane helices toward their active
state (Fleishman et al., 2002; Jiang and Hunter, 1999; The proposed molecular model may explain the un-
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derlying molecular causes of malignancy mediated by has yet to be determined. The importance of the inter-
face between the kinase domain and the C-terminalEGFRs that contain mutations in their C-terminal do-
main. According to the model, the transforming proper- fragment for the regulation of EGFR activity can be
tested experimentally, as delineated in the section enti-ties of these mutations (Boerner et al., 2003; Chang et
al., 1995; Frederick et al., 2000) are due to destabilization tled “A Network of Ion Pairs and Hydrogen Bonds at the
Interface.”of the inactive EGFR.
All TKs catalyze the same reaction, which is the trans- Our model of EGFR’s regulation (Figure 1) and its
relevance to cancer could be further tested by examin-fer of the -phosphate of ATP to the hydroxyl group of
tyrosine. Indeed, the active conformation of the kinase ing the properties of a short peptide analog to the
C-terminal fragment. Such a peptide may have a regula-domain of most TKs is nearly identical. In contrast to
the uniform active conformation, TKs differ from each tory effect on EGFR activation. For instance, in tumori-
genic cells, the short peptide may associate with theother in their inactive conformations (Huse and Kuriyan,
2002). In some RTKs, as in the PDGFR family, the juxta- kinase domain instead of the truncated C-terminal do-
main. This would stabilize the inactive configuration andmembrane domain serves to block the active conforma-
tion. Autophosphorylation of tyrosine residues in highly thereby thwart the constitutive activation of the mutant
receptor. Interestingly, a similar approach was appliedconserved juxtamembrane motifs, specific to each fam-
ily, relieves autoinhibition (Griffith et al., 2004). In the successfully in a recent study on the PDGFR, which is
also selfinhibited by direct contact with its C-terminalcase of the EGFR family, inhibition by the juxtamem-
brane domain is less likely, since there are no tyrosine domain (Chiara et al., 2004). In this work, the authors
showed that a soluble peptide, corresponding to theresidues in the juxtamembrane segment that can be
phosphorylated. inhibitory fragment in the PDGFR C-terminal domain,
delayed the activation of the receptor and inhibited theVarious regulatory mechanisms could play an impor-
tant role in ensuring the signaling specificity in the TK enhanced kinase activity of a C-terminal truncated
PDGFR. Hence, the small peptide mimicked the rolesuperfamily. Accordingly, we suggest that certain amino
acid substitutions in regulatory elements were sustained of the C-terminal fragment in regulating kinase activity
(Chiara et al., 2004). It will be interesting to examine theduring evolution, leading to alterations in the regulatory
mechanisms. This hypothesis is supported by the analy- therapeutic properties of such a peptide in the case of
the EGFR.sis of specificity determinants (Figure 7B). In the vast
majority of the TKs, kinase activity is regulated through
Experimental Proceduresa change in the conformation of the activation loop and
C helix. Nevertheless, these regulatory regions un-
Biophysical and Structural Analysisdergo different conformational changes in different iso-
Electrostatic, solvent-accessible surface area calculations and ho-
forms, and their inactive conformations are stabilized mology modeling were carried out as described in the Supplemental
by fastidious means specific to each kinase family (Huse Data.
and Kuriyan, 2002). The ErbBs are further exceptional
Collection of Sequence Homologs and Their Alignmentamong TKs, in that the activation loop and C helix are
A multiple-sequence alignment (MSA) of homologous kinase do-constitutively stable in the active conformation (Stamos
mains was produced by combining multiple-structure and sequenceet al., 2002). Our analysis of correlated mutations (Figure
alignments to obtain high-quality alignments as described by Al-
7A) suggests that in order to complement the role of Lazikani et al. (2001) and in the Supplemental Data. This resulted
these known regulatory elements in maintaining an ac- in an MSA of 121 homologous sequences comprising the kinase
tive conformation, other residues in ErbBs have evolved domain and about 50 positions C-terminal to it (corresponding to
positions 683–998 of the EGFR). The MSA is shown in Supplementalto keep the enzyme dormant, as in the “inactive” com-
Figure S1 in the Supplemental Data.plex shown in Figure 2A.
We propose that members of the EGFR family utilize
Evolutionary Conservationthe unique regulatory mechanism that is presented in
Evolutionary conservation scores were calculated by using the MSA
Figure 1. These receptors contain a long C-terminal do- and Rate4Site’s maximum-likelihood algorithm (Pupko et al., 2002),
main that is involved in signal transmission inside the as implemented in the ConSurf web server (Glaser et al., 2003)
cell and is also an inherent regulator of kinase activity (http://consurf.tau.ac.il/).
(Chang et al., 1995). Our results suggest that the com-
Correlated Amino Acid Substitutionsplex between the kinase and C-terminal domains of Fig-
Pairs of amino acids that appear to change concomitantly duringure 2A is stable and biologically significant, as indicated
evolution within the TKs were detected by using the MSA and theby the large intersubunit interface, the electrostatic and
CorrMut algorithm (Fleishman et al., 2004b). The methodological
geometric complementarity between the C-terminal details are provided as Supplemental Data.
segments and the kinases (Figures 2B–2D and 5), as
well as the evolutionary correlation between specified Specificity Determinants
amino acid sites (Figure 7A). This complex appears to Residues in the TK superfamily, which may be responsible for de-
termining specific characteristics in different kinase families, werecorrespond to the basal, inactive form of the receptor,
detected by using the MSA and the SpecDet algorithm (Fleishmanas delineated above and in accordance with previous
et al., 2004a). A description of the algorithm is provided as Supple-experimental data (Boerner et al., 2003; Chang et al.,
mental Data.1995). Although our computational analysis and the ex-
perimental data support the presence of an inactive
Supplemental Data
dimer (Yu et al., 2002) and the necessity of contact Supplemental Data including analysis of the electrostatic potential
between the kinase and C-terminal domains (Chang et of representative TKs of known structure; solvent-accessible sur-
face area calculations and homology modeling of selected TKs;al., 1995), the biological relevance of the crystal dimer
Structure
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the MSA of the TK family; methodological details of the correlated Fleishman, S.J., Unger, V.M., Yeager, M., and Ben-Tal, N. (2004a). A
C-alpha model for the transmembrane alpha-helices of gap-junctionmutations analysis; and a description of the algorithm used for de-
tecting the specificity-determining residues are available at http:// intercellular channels. Mol. Cell 15, 879–888.
www.structure.org/cgi/content/full/12/12/2265/DC1/. Fleishman, S.J., Yifrach, O., and Ben-Tal, N. (2004b). An evolution-
arily conserved network of amino acids mediates gating in voltage-
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